ChemicalBook > Product Catalog >API >Drugs Influencing Immune Function >Immunomodulators >Burosumab

Burosumab

Request For Quotation
Burosumab Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: BOC Sciences  
Tel: 16314854226; +8616314854226
Email: inquiry@bocsci.com
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Email: 981810490@qq.com
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com
Burosumab Basic information
Product Name:Burosumab
Synonyms:Burosumab;Research Grade Burosumab(DHJ53401);KRN23;Research Grade Burosumab;Burosumab (Anti-FGF23)
CAS:1610833-03-8
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Burosumab Structure
Burosumab Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Burosumab Usage And Synthesis
UsesBurosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia[1][2].
References[1] Schindeler A, et al. Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children. Front Endocrinol (Lausanne). 2020 May 28;11:338. DOI:10.3389/fendo.2020.00338
[2] Colangelo L, et al. Appropriate dosing of burosumab in tumor-induced osteomalacia. Osteoporos Int. 2022 Dec 1. DOI:10.1007/s00198-022-06617-2
Burosumab Preparation Products And Raw materials
Tag:Burosumab(1610833-03-8) Related Product Information
Manelimab Ponezumab Brentuximab Rolinsatamab Simtuzumab Nipocalimab Fulranumab Zolbetuximab Carlumab Belantamab